RICHARD LOWENTHAL plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144

RICHARD LOWENTHAL filed Form 144 to notify SEC of plan to sell 840 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-02, with aggregate market value of $4,999.76. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 08/20/2026, sold 25000 units for $148160.00; On 08/19/2026, sold 50000 units for $322345.00; On 08/18/2026, sold 50000 units for $315885.00;